Intellia Thera CS (NTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 147,781 | 133,382 | 123,406 | 334,736 | 129,879 |
| Marketable Securities | 726,494 | 721,869 | 625,282 | 463,531 | 399,140 |
| Receivables | 2,854 | 1,801 | 2,031 | 2,491 | 1,993 |
| TOTAL | $895,433 | $875,367 | $769,303 | $814,774 | $549,404 |
| Non-Current Assets | |||||
| PPE Net | 25,868 | 23,697 | 20,968 | 19,946 | 18,530 |
| Investments And Advances | 78,220 | 191,758 | 395,492 | 413,288 | 22,262 |
| Other Non-Current Assets | 110,903 | 111,966 | 108,701 | 86,953 | 82,047 |
| TOTAL | $214,991 | $327,421 | $525,161 | $520,187 | $122,839 |
| Total Assets | $1,110,424 | $1,202,788 | $1,294,464 | $1,334,961 | $672,243 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,515 | 10,138 | 9,653 | 7,470 | 6,854 |
| Accrued Expenses | 44,871 | 42,876 | 43,309 | 24,633 | 37,150 |
| TOTAL | $123,760 | $126,111 | $125,833 | $97,567 | $73,963 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 61,806 | 63,759 | 63,759 | 56,759 | 22,544 |
| Other Non-Current Liabilities | 70,787 | 73,442 | 64,911 | 67,273 | 63,259 |
| TOTAL | $106,117 | $122,923 | $128,387 | $130,296 | $103,467 |
| Total Liabilities | $229,877 | $249,034 | $254,220 | $227,863 | $177,430 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 76,012 | 75,854 | 74,672 | 74,419 | 73,487 |
| Common Shares | 8 | 8 | 7 | 7 | 7 |
| Retained earnings | -950,551 | -849,873 | -703,001 | -621,764 | -550,120 |
| Other shareholders' equity | -9,554 | -8,062 | -2,632 | -174 | -13 |
| TOTAL | $880,547 | $953,754 | $1,040,244 | $1,107,098 | $494,813 |
| Total Liabilities And Equity | $1,110,424 | $1,202,788 | $1,294,464 | $1,334,961 | $672,243 |